Linked Life Data

10362523

Source:http://linkedlifedata.com/resource/pubmed/id/10362523

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10362523rdf:typepubmed:Citationlld:pubmed
pubmed-article:10362523lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0004153lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0132555lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0360714lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0162493lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0684321lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0428462lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C1287373lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C0392760lld:lifeskim
pubmed-article:10362523lifeskim:mentionsumls-concept:C2347946lld:lifeskim
pubmed-article:10362523pubmed:issue2lld:pubmed
pubmed-article:10362523pubmed:dateCreated1999-6-28lld:pubmed
pubmed-article:10362523pubmed:abstractTextWe determined the role of Fluvastatin: HMG-CoA reductase inhibitor on the regression of atherosclerosis following removal of dietary cholesterol. Male rabbits fed a 0.5% cholesterol diet for 12 weeks were divided into three groups: A1, hypercholesterolemic; A2, fed a regular diet for an 12 additional weeks; and A3, fed a regular diet with fluvastatin (2 mg/kg/day). Fluvastatin treatment (A3) did not affect serum lipid levels compared with A2. However, it decreased the atherosclerotic area in the aortic arch and decreased total and esterified cholesterol concentrations in the descending aorta. Tone-related basal NO release in the thoracic aorta was larger in A3 than in A2. eNOS mRNA in vessel was determined by competitive RT-PCR assay. It increased in A1, compared with normal aorta and decreased in A2; however, it did not decrease in A3. This is the first report of a decrease in eNOS mRNA in atherosclerosis after removal of dietary cholesterol and a reversal of it by a HMG-CoA reductase inhibitor, which may contribute to the regression of atherosclerosis.lld:pubmed
pubmed-article:10362523pubmed:languageenglld:pubmed
pubmed-article:10362523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:citationSubsetIMlld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10362523pubmed:statusMEDLINElld:pubmed
pubmed-article:10362523pubmed:monthJunlld:pubmed
pubmed-article:10362523pubmed:issn0006-291Xlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:HayashiTTlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:EsakiTTlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:KanoHHlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:AsaiYYlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:IguchiAAlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:SuszC PCPlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:ThakurN KNKlld:pubmed
pubmed-article:10362523pubmed:authorpubmed-author:JayachandranM...lld:pubmed
pubmed-article:10362523pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10362523pubmed:issnTypePrintlld:pubmed
pubmed-article:10362523pubmed:day7lld:pubmed
pubmed-article:10362523pubmed:volume259lld:pubmed
pubmed-article:10362523pubmed:ownerNLMlld:pubmed
pubmed-article:10362523pubmed:authorsCompleteYlld:pubmed
pubmed-article:10362523pubmed:pagination414-9lld:pubmed
pubmed-article:10362523pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:meshHeadingpubmed-meshheading:10362523...lld:pubmed
pubmed-article:10362523pubmed:year1999lld:pubmed
pubmed-article:10362523pubmed:articleTitleA HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA.lld:pubmed
pubmed-article:10362523pubmed:affiliationDepartment of Geriatrics, Nagoya University Graduate School of Medicine, 466-8550, Japan.lld:pubmed
pubmed-article:10362523pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10362523pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10362523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10362523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10362523lld:pubmed